Antiviral Therapy for Chronic Hepatitis B Virus Infection and Development of Hepatocellular Carcinoma in a US Population-Reference-Cited by-同舟云学术

Antiviral Therapy for Chronic Hepatitis B Virus Infection and Development of Hepatocellular Carcinoma in a US Population

Published:2014-05 Issue:5 Volume:12 Page:885-893
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Gordon Stuart C.,Lamerato Lois E.,Rupp Loralee B.,Li Jia,Holmberg Scott D.,Moorman Anne C.,Spradling Philip R.,Teshale Eyasu H.,Vijayadeva Vinutha,Boscarino Joseph A.,Henkle Emily M.,Oja–Tebbe Nancy,Lu Mei

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference19 articles.

1. Prevention of hepatitis B virus-related hepatocellular carcinoma with antiviral therapy;Lai;Hepatology,2013

2. Meta-analysis: the impact of oral anti-viral agents on the incidence of hepatocellular carcinoma in chronic hepatitis B;Singal;Aliment Pharmacol Ther,2013

3. Effect of nucleos(t)ide analogue therapy on hepatocarcinogenesis in chronic hepatitis B patients: a propensity score analysis;Kumada;J Hepatol,2013

4. Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis;Wong;Hepatology,2013

5. Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection;Hosaka;Hepatology,2013

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contemporary epidemiology of hepatocellular carcinoma: understanding risk factors and surveillance strategies;Journal of the Canadian Association of Gastroenterology;2024-08-09

2. Antiviral therapy improves postoperative survival in elderly HBV-related HCC patients: a propensity score analysis;2024-07-27

3. “PROTAC” modified dihydroquinolizinones (DHQs) that cause degradation of PAPD-5 and inhibition of hepatitis A virus and hepatitis B virus, in vitro;Bioorganic & Medicinal Chemistry Letters;2024-04

4. Disparities in Social Vulnerability and Premature Mortality among Decedents with Hepatitis B, United States, 2010–2019;Journal of Racial and Ethnic Health Disparities;2024-03-12

5. Metabolic dysfunction-associated steatotic liver disease increases hepatocellular carcinoma risk in chronic hepatitis B patients: a retrospective cohort study;Frontiers in Physiology;2024-02-09